Category: Synchronous

New Ophthalmic Drugs & Drug Delivery Systems

September 21, 2026
TUESDAY, DECEMBER 15, 2026: This course reviews advances in ophthalmic drug delivery and newly approved ophthalmic drugs, emphasizing evidence-based treatment options, clinical applications, benefits, limitations, and considerations for optometric and ophthalmologic practice.
Read More »

Genetics & Glaucoma: Implications for Optometric Practice

September 21, 2026
TUESDAY, OCTOBER 20, 2026: Glaucoma is a general term for a group of complex disorders that result in progressive degeneration of the optic nerve. It is a leading cause of worldwide blindness. Emerging genetic tests have been investigational but are now commercially available to inform patients of their risk assessment and provide optometrists and ophthalmologists with tools to improve patient outcomes.
Read More »